Developing tools to understand immune responses for HIV/AIDS treatment
NIH TETRAMER CORE FACILITY (HIV/AIDS)
This study is all about helping scientists learn more about how our immune system fights HIV/AIDS, so they can create better vaccines and treatments that could eventually help patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10812211 on NIH RePORTER |
What this research studies
This research focuses on enhancing our understanding of immune responses related to HIV/AIDS, aiming to develop effective vaccines and therapeutic agents. It involves the synthesis and distribution of Major Histocompatibility Complex (MHC) tetramer reagents, which are crucial for studying how the immune system recognizes and responds to HIV. By providing these resources to researchers worldwide, the project seeks to improve public health outcomes related to infectious diseases. Patients may benefit indirectly through advancements in treatment options and vaccine development.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by HIV/AIDS or those at high risk of infection.
Not a fit: Patients with non-infectious diseases or those not affected by HIV/AIDS may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccines and therapies for HIV/AIDS, enhancing patient care and outcomes.
How similar studies have performed: Previous research has shown success in using MHC tetramer technology to advance our understanding of immune responses, indicating a promising approach.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Altman, John — Emory University
- Study coordinator: Altman, John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.